PARISSA FERGUSON: Open Payments
NPI 1649882556 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 27 payments from 10 companies in 2025. Trend: 2023 $641 · 2024 $556 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $124 |
| Novo Nordisk Inc | 5 | $95 |
| Madrigal Pharmaceuticals | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Corcept Therapeutics | 2 | $45 |
| Amgen Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Ionis Pharmaceuticals, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: REZDIFFRA, Wegovy, CREON, LEQVIO, Korlym, UBRELVY, Repatha, MOUNJARO.
Industry payments across OK — which companies pay providers there.
